Filtered By:
Source: Journal of Stroke and Cerebrovascular Diseases
Nutrition: Vitamin D

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

Association between white matter hyperintensity volume and social functioning limitations among stroke survivors
Existing literature on white matter hyperintensity volume (WMHV) in stroke patients has rarely focused on post-stroke outcomes related to social functioning limitations, such as transportation, social interaction, food preparation, grocery shopping, and housekeeping. Using prospective data from the VITamin D and OmegA-3 TriaL (VITAL) study, we evaluated the association between WMHV and social functioning limitations among 151 ischemic stroke patients.
Source: Journal of Stroke and Cerebrovascular Diseases - September 1, 2022 Category: Neurology Authors: Flora G. Chang, Natalia S. Rost, JoAnn E. Manson, Julie E. Buring, Pamela M. Rist Source Type: research

Use of Antipsychotics is Negatively Associated with Muscle Strength in Older Adults with Sarcopenia after Stroke
The mainstay of treatment for sarcopenia is muscle mass and strength increase through exercise and nutritional intervention.1 A systematic review and meta-analysis of the effects of combined exercise and nutritional therapy for sarcopenia in older people showed that this combination may have positive effects on improving walking speed within 3 months of intervention.2 Furthermore, supplementation with whey protein, essential amino acids, and vitamin D, in conjunction with age-appropriate exercise has been reported to boost fat-free mass and strength.
Source: Journal of Stroke and Cerebrovascular Diseases - July 3, 2022 Category: Neurology Authors: Eiji Kose, Yoshihiro Yoshimura, Hidetaka Wakabayashi, Ayaka Matsumoto Source Type: research

Platelet Surface CD62p and Serum Vitamin D Levels are Associated with Clopidogrel Resistance in Chinese Patients with Ischemic Stroke
Background: To explore the association of platelet activation markers, vitamin D, and antiplatelet drugs resistance in ischemic stroke patients. Methods: A total of 230 patients with ischemic stroke were enrolled in this study. Platelet aggregation, platelet activation marker (CD62p), and vitamin D were measured after 7-14 days of dual antiplatelet treatment (aspirin  + clopidogrel). All individuals were divided into a drug resistance group and a drug sensitive group according to the platelet maximum aggregation rate induced by antagonist adenosine diphosphate or arachidonic acid.
Source: Journal of Stroke and Cerebrovascular Diseases - February 20, 2019 Category: Neurology Authors: Bi-Chao Lu, Xiao-Jie Shi, Lin Liang, Na Dong, Zhi-Zhong Liu Source Type: research

Unusual Intracranial Arterial Calcification and Vitamin D Deficiency
In conclusion, although the role of IAC in cerebral infarction is still controversial, we suggest that insufficient vitamin D should be examined and treated appropriately in all patients with IS.
Source: Journal of Stroke and Cerebrovascular Diseases - October 26, 2017 Category: Neurology Authors: Yerim Kim, Jong Seok Bae, Hong-Ki Song, Ju-Hun Lee Tags: Case Studies Source Type: research